Dublin-based biotech Nuritas says the closing of a â16 million of series A funding will allow it to scale up and grasp the âhuge opportunitiesâ for the discovery and use of bioactive peptides through artificial intelligence (AI) and genomics.
Read more about it via http://bit.ly/2BtADlX
No comments:
Post a Comment